Active Ingredient(s):Dexrazoxane FDA Approved: * May 26, 1995 Pharm Company: *PHARMACIA AND UPJOHN Category:Cancer
Dexrazoxane hydrochloride (Zinecard, Cardioxane) is a cardioprotective agent. It was discovered by Eugene Herman in 1972. The IV administration of dexrazoxane is in acidic condition with HCl adjusting the pH.
4 External links
Dexrazoxane has been used to protect the heart against the cardiotoxic side effects of chemotherapeutic drugs such as anthracyclines, such as daunorubicin or doxorubicin or other c...
* May have multiple approval dates, manufacturers, or labelers.
Zinecard 250 mg/25ml Intravenous Injection, Powder, Lyophilized, for Solution